The Unpublished Phase I Trial: A Critical Look A pivotal point of discussion is the Phase I clinical trial for BPC-157 in patients with IBD, registered on ClinicalTrials.gov
trials reporting phenotypic or subgroup analyses on pharmacologic obesity treatments
However, outcomes depend not only on the injection itself, but on how it fits into a broader skin strategy
STNF- is biologically active as a homotrimer and acts through binding to the TNFR1 receptor
Features that tend to point towards BAD rather than general Mounjaro side effects: Urgent, watery diarrhoea that persists beyond the first few weeks on a stable Mounjaro dose Symptoms worse after meals, particularly those higher in fat Yellowish or greasy stools Frequent morning bowel movements Diarrhoea that started after your cholecystectomy and hasnt settled, predating your time on Mounjaro If you suspect BAD, speak to your GP
I am so happy with the results I have lost 4 inches , the experience so far has been good, except for one day I did the injection I forgot I wasnt supposed to have any alcohol, and It made me sick